Park Ha Biological Technology Co Ltd (NASDAQ: PHH) has a price-to-earnings ratio that is above its average at 132.82x. Opinions on the stock are mixed, with 2 analysts rating it as a “buy,” 2 as “overweight,” 3 as “hold,” and 0 as “sell.”
The public float for PHH is 4.82M, and at present, short sellers hold a 0.07% of that float. On March 10, 2025, the average trading volume of PHH was 135.15K shares.
PHH) stock’s latest price update
The stock price of Park Ha Biological Technology Co Ltd (NASDAQ: PHH) has jumped by 11.45 compared to previous close of 6.90. Despite this, the company has seen a gain of 46.76% in its stock price over the last five trading days. globenewswire.com reported 2025-03-06 that WEST PALM BEACH, Fla., March 06, 2025 (GLOBE NEWSWIRE) — PHH Mortgage (“PHH” or the “Company”), a subsidiary of Onity Group Inc. (NYSE: ONIT) and a leading non-bank mortgage servicer and originator, today announced the Company achieved Fannie Mae’s 2024 Servicer Total Achievement and Rewards™ (STAR™) Performer recognition in the General Servicing category.
PHH’s Market Performance
The volatility ratio for the week is 21.56%, and the volatility levels for the past 30 days are at 11.50% for PHH. The simple moving average for the past 20 days is 33.89% for PHH’s stock, with a 38.44% simple moving average for the past 200 days.
PHH Trading at 38.44% from the 50-Day Moving Average
After a stumble in the market that brought PHH to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -1.54% of loss for the given period.
Volatility was left at 11.50%, however, over the last 30 days, the volatility rate increased by 21.56%, as shares surge +40.33% for the moving average over the last 20 days.
During the last 5 trading sessions, PHH rose by +46.76%, in comparison to the 20-day moving average, which settled at $5.74. In addition, Park Ha Biological Technology Co Ltd saw 22.26% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for PHH
Current profitability levels for the company are sitting at:
- 0.33 for the present operating margin
- 0.92 for the gross margin
The net margin for Park Ha Biological Technology Co Ltd stands at 0.2. The total capital return value is set at 0.51. Equity return is now at value 38.00, with 17.89 for asset returns.
Based on Park Ha Biological Technology Co Ltd (PHH), the company’s capital structure generated 0.04 points at debt to capital in total, while cash flow to debt ratio is standing at 13.66.
Currently, EBITDA for the company is 0.82 million with net debt to EBITDA at -0.58. When we switch over and look at the enterprise to sales, we see a ratio of 84.95. The receivables turnover for the company is 2.15for trailing twelve months and the total asset turnover is 0.77. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.15.
Conclusion
To sum up, Park Ha Biological Technology Co Ltd (PHH) has seen a better performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
